• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在生命的最后一年,按死亡模式(来自 HF-ACTION 随机对照试验)划分的住院资源使用和医疗费用。

In-hospital resource use and medical costs in the last year of life by mode of death (from the HF-ACTION randomized controlled trial).

机构信息

Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA.

出版信息

Am J Cardiol. 2012 Oct 15;110(8):1150-5. doi: 10.1016/j.amjcard.2012.05.059. Epub 2012 Jul 3.

DOI:10.1016/j.amjcard.2012.05.059
PMID:22762718
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3462294/
Abstract

Patterns of medical resource use near the end of life may differ across modes of death. The aim of this study was to characterize patterns of inpatient resource use and direct costs for patients with heart failure (HF) who died of sudden cardiac death (SCD), HF, other cardiovascular causes, or noncardiovascular causes during the last year of life. Data were from a randomized trial of exercise training in patients with HF. Mode of death was adjudicated by an end point committee. Generalized estimating equations were used to compare hospitalizations, inpatient days, and inpatient costs incurred during the final year of life in patients who died of different causes, adjusting for clinical and treatment characteristics. Of 2,331 patients enrolled in the trial, 231 died after ≥1 year of follow-up with an adjudicated mode of death, including 72 of SCD, 80 of HF, 34 of other cardiovascular causes, and 45 of noncardiovascular causes. Patients who died of SCD were younger, had less severe HF, and incurred fewer hospitalizations, fewer inpatient days, and lower inpatient costs than patients who died of other causes. After adjustment for patient characteristics, inpatient resource use varied by 2 to 4 times across modes of death, suggesting that cost-effectiveness analyses of interventions that reduce mortality from SCD compared to other causes should incorporate mode-specific end-of-life costs. In conclusion, resource use and associated medical costs in the last year of life differed markedly in patients with HF who experienced SCD and patients who died of other causes.

摘要

在生命末期,不同的死亡模式下医疗资源的使用模式可能存在差异。本研究的目的是描述心力衰竭(HF)患者在生命的最后一年中因心源性猝死(SCD)、HF、其他心血管原因或非心血管原因死亡的住院资源使用和直接成本模式。数据来自 HF 患者运动训练的随机试验。死亡模式由终点委员会判定。使用广义估计方程比较不同死亡原因患者在生命最后一年的住院次数、住院天数和住院费用,同时调整临床和治疗特征。在试验中,共有 2331 名患者入组,其中 231 名患者在≥1 年的随访后死亡,并确定了死亡模式,包括 72 例 SCD、80 例 HF、34 例其他心血管原因和 45 例非心血管原因。SCD 死亡患者年龄较小,HF 程度较轻,住院次数、住院天数和住院费用均低于其他原因死亡患者。调整患者特征后,不同死亡模式的住院资源使用差异达 2 至 4 倍,这表明与其他原因相比,降低 SCD 死亡率的干预措施的成本效益分析应纳入特定模式的临终成本。总之,心力衰竭患者中因 SCD 和其他原因死亡的患者在生命的最后一年中资源使用和相关医疗费用差异显著。

相似文献

1
In-hospital resource use and medical costs in the last year of life by mode of death (from the HF-ACTION randomized controlled trial).在生命的最后一年,按死亡模式(来自 HF-ACTION 随机对照试验)划分的住院资源使用和医疗费用。
Am J Cardiol. 2012 Oct 15;110(8):1150-5. doi: 10.1016/j.amjcard.2012.05.059. Epub 2012 Jul 3.
2
Health Care Costs for Patients with Heart Failure Escalate Nearly 3-Fold in Final Months of Life.心力衰竭患者在生命的最后几个月中医疗费用几乎增加了 3 倍。
J Manag Care Spec Pharm. 2016 Dec;22(12):1446-1456. doi: 10.18553/jmcp.2016.22.12.1446.
3
Resource use in the last 6 months of life among medicare beneficiaries with heart failure, 2000-2007.2000 - 2007年医疗保险受益人中,心力衰竭患者生命最后6个月的资源使用情况。
Arch Intern Med. 2011 Feb 14;171(3):196-203. doi: 10.1001/archinternmed.2010.371. Epub 2010 Oct 11.
4
Resource use in the last 6 months of life among patients with heart failure in Canada.加拿大心力衰竭患者生命最后6个月的资源使用情况。
Arch Intern Med. 2011 Feb 14;171(3):211-7. doi: 10.1001/archinternmed.2010.365. Epub 2010 Oct 11.
5
[Patients with heart failure in the last year of their life: the primary care perspective].[生命最后一年的心力衰竭患者:基层医疗视角]
G Ital Cardiol (Rome). 2014 Oct;15(10):569-76. doi: 10.1714/1672.18310.
6
The healthcare costs of heart failure during the last five years of life: A retrospective cohort study.生命最后五年中心力衰竭的医疗费用:一项回顾性队列研究。
Int J Cardiol. 2016 Dec 1;224:132-138. doi: 10.1016/j.ijcard.2016.09.021. Epub 2016 Sep 15.
7
Economic evaluation of the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) randomized controlled trial: an exercise training study of patients with chronic heart failure.心力衰竭:运动训练效果的对照试验(HF-ACTION)随机对照试验的经济学评估:一项针对慢性心力衰竭患者的运动训练研究。
Circ Cardiovasc Qual Outcomes. 2010 Jul;3(4):374-81. doi: 10.1161/CIRCOUTCOMES.109.907287. Epub 2010 Jun 15.
8
Associations between seattle heart failure model scores and medical resource use and costs: findings from HF-ACTION.西雅图心力衰竭模型评分与医疗资源利用及成本之间的关联:心力衰竭:一项临床试验(HF-ACTION)的研究结果
J Card Fail. 2014 Aug;20(8):541-7. doi: 10.1016/j.cardfail.2014.05.009. Epub 2014 Jun 2.
9
Influence of carvedilol on hospitalizations in heart failure: incidence, resource utilization and costs. U.S. Carvedilol Heart Failure Study Group.卡维地洛对心力衰竭住院率的影响:发病率、资源利用及成本。美国卡维地洛心力衰竭研究组。
J Am Coll Cardiol. 2001 May;37(6):1692-9. doi: 10.1016/s0735-1097(01)01190-1.
10
Validating the use of Hospital Episode Statistics data and comparison of costing methodologies for economic evaluation: an end-of-life case study from the Cluster randomised triAl of PSA testing for Prostate cancer (CAP).验证医院诊疗统计数据的使用及经济评估成本核算方法的比较:前列腺癌PSA检测整群随机试验(CAP)的终末期病例研究
BMJ Open. 2016 Apr 29;6(4):e011063. doi: 10.1136/bmjopen-2016-011063.

引用本文的文献

1
Long-Term Outcomes of Heart Failure With Preserved or Mid-Range Ejection Fraction in the United States.美国射血分数保留或处于中等范围的心力衰竭的长期结局
JACC Adv. 2024 Jul 24;3(7):101027. doi: 10.1016/j.jacadv.2024.101027. eCollection 2024 Jul.
2
Exercise-based cardiac rehabilitation for adults with heart failure.针对心力衰竭成人患者的基于运动的心脏康复。
Cochrane Database Syst Rev. 2024 Mar 7;3(3):CD003331. doi: 10.1002/14651858.CD003331.pub6.
3
Factors associated with hospitalisations of patients with chronic heart failure approaching the end of life: A systematic review.

本文引用的文献

1
Treatment and outcomes for congestive heart failure by race/ethnicity in TRICARE.TRICARE 中按种族/民族划分的充血性心力衰竭的治疗和结果。
Med Care. 2011 May;49(5):489-95. doi: 10.1097/MLR.0b013e318207ef87.
2
Thirty-day readmission rates for Medicare beneficiaries by race and site of care.按种族和护理地点划分的 Medicare 受益人的 30 天再入院率。
JAMA. 2011 Feb 16;305(7):675-81. doi: 10.1001/jama.2011.123.
3
Lifetime costs of medical care after heart failure diagnosis.心力衰竭诊断后的终身医疗费用。
与接近生命终点的慢性心力衰竭患者住院相关的因素:系统评价。
Palliat Med. 2022 Dec;36(10):1452-1468. doi: 10.1177/02692163221123422. Epub 2022 Sep 28.
4
Cost-effectiveness of Dapagliflozin for Treatment of Patients With Heart Failure With Reduced Ejection Fraction.达格列净治疗射血分数降低的心力衰竭患者的成本效益分析。
JAMA Cardiol. 2021 Aug 1;6(8):926-935. doi: 10.1001/jamacardio.2021.1437.
5
Exercise-based cardiac rehabilitation for adults with heart failure.针对成年心力衰竭患者的运动心脏康复治疗。
Cochrane Database Syst Rev. 2019 Jan 29;1(1):CD003331. doi: 10.1002/14651858.CD003331.pub5.
6
The use of hospital-based services by heart failure patients in the last year of life: a discussion paper.终末期心衰患者在生命最后一年的住院服务使用情况:讨论稿。
Heart Fail Rev. 2019 Mar;24(2):199-207. doi: 10.1007/s10741-018-9751-7.
7
Home-based versus centre-based cardiac rehabilitation.家庭式与中心式心脏康复
Cochrane Database Syst Rev. 2017 Jun 30;6(6):CD007130. doi: 10.1002/14651858.CD007130.pub4.
8
Does the Implantable Cardioverter-Defibrillator Benefit Vary With the Estimated Proportional Risk of Sudden Death in Heart Failure Patients?植入式心脏复律除颤器的获益是否因心力衰竭患者猝死的预计比例风险而异?
JACC Clin Electrophysiol. 2017 Mar;3(3):291-298. doi: 10.1016/j.jacep.2016.09.006.
9
Patient-level costs of major cardiovascular conditions: a review of the international literature.主要心血管疾病的患者层面成本:国际文献综述
Clinicoecon Outcomes Res. 2016 Sep 21;8:495-506. doi: 10.2147/CEOR.S89331. eCollection 2016.
10
Validating the use of Hospital Episode Statistics data and comparison of costing methodologies for economic evaluation: an end-of-life case study from the Cluster randomised triAl of PSA testing for Prostate cancer (CAP).验证医院诊疗统计数据的使用及经济评估成本核算方法的比较:前列腺癌PSA检测整群随机试验(CAP)的终末期病例研究
BMJ Open. 2016 Apr 29;6(4):e011063. doi: 10.1136/bmjopen-2016-011063.
Circ Cardiovasc Qual Outcomes. 2011 Jan 1;4(1):68-75. doi: 10.1161/CIRCOUTCOMES.110.957225. Epub 2010 Dec 7.
4
Hospice use among urban Black and White U.S. nursing home decedents in 2006.2006 年美国城市中黑人和白人养老院死者的临终关怀使用情况。
Gerontologist. 2011 Apr;51(2):251-60. doi: 10.1093/geront/gnq093. Epub 2010 Nov 12.
5
Resource use in the last 6 months of life among medicare beneficiaries with heart failure, 2000-2007.2000 - 2007年医疗保险受益人中,心力衰竭患者生命最后6个月的资源使用情况。
Arch Intern Med. 2011 Feb 14;171(3):196-203. doi: 10.1001/archinternmed.2010.371. Epub 2010 Oct 11.
6
Economic evaluation of the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) randomized controlled trial: an exercise training study of patients with chronic heart failure.心力衰竭:运动训练效果的对照试验(HF-ACTION)随机对照试验的经济学评估:一项针对慢性心力衰竭患者的运动训练研究。
Circ Cardiovasc Qual Outcomes. 2010 Jul;3(4):374-81. doi: 10.1161/CIRCOUTCOMES.109.907287. Epub 2010 Jun 15.
7
Racial and ethnic disparities within and between hospitals for inpatient quality of care: an examination of patient-level Hospital Quality Alliance measures.医院内部及之间住院医疗质量的种族和族裔差异:对患者层面医院质量联盟指标的考察。
J Health Care Poor Underserved. 2010 May;21(2):629-48. doi: 10.1353/hpu.0.0281.
8
Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial.慢性心力衰竭患者运动训练的疗效与安全性:HF-ACTION随机对照试验
JAMA. 2009 Apr 8;301(14):1439-50. doi: 10.1001/jama.2009.454.
9
The cost of medical management in advanced heart failure during the final two years of life.晚期心力衰竭患者生命最后两年的医疗管理成本。
J Card Fail. 2008 Oct;14(8):651-8. doi: 10.1016/j.cardfail.2008.06.005. Epub 2008 Jul 21.
10
Racial disparity in hospice use in the United States in 2002.2002年美国临终关怀使用方面的种族差异。
Palliat Med. 2008 Apr;22(3):205-13. doi: 10.1177/0269216308089305.